Deletion of the q14 region of chromosome 13 in CLL cases is often met with a favorable prognosis, citing the loss of miR-15/16, DLEU7, or RB1 as major contributors to disease pathogenesis [81–83]. This evidence concerns the gene DLEU7 and B-cell chronic lymphocytic leukemia.